Skin conditions (dermatitis, eczema, psoriasis) Board decisions

The Board remands the claim for a new VA opinion as the previous one was deemed inadequate.

The Veteran's lower back disability is increased to 20 percent disabling, and the service connection for right ear hearing loss and cervical strain is granted.,The appeal for an increased rating for radiculopathy of the left lower extremity was denied.,The appeals for service connection for left ear hearing loss, CFS, constipation, functional abdominal pain syndrome/abdominal pain and bloating/GERD, and respiratory insufficiency (dyspnea) were denied.,Service connection for dry eyes is granted, and the right hip pain is secondary to the Veteran's service-connected lower back disability.

The Board granted service connection for a skin condition manifest by acne and associated scarring, finding that new and relevant evidence had been submitted since the previous denial.

The Board remands the claim for service connection for tinea pedis to correct a pre-decisional duty to assist error, as relevant medical records were not obtained prior to the rating decision.

The Board granted service connection for candidiasis with bacterial vaginosis and bilateral pes planus with plantar fasciitis, but denied service connection for eczema of the scalp and face. The claim for service connection for bilateral hearing loss was remanded.

The Board dismissed the appeals for service connection and increased rating claims as they were not properly filed within the required time frame.

The Board denied service connection for scars of the BUE, BLE, face, head, and back, and denied earlier effective dates for the grants of service connection for acne, rhinitis, and sinusitis. The Board granted a 10 percent evaluation for service-connected sinusitis but denied compensable ratings for service-connected acne and rhinitis.

The Board remands the issues of entitlement to a compensable rating for bilateral hearing loss, service connection for tinea pedis (Athletes Foot), lumbar spine disability, and an acquired psychiatric disability due to duty to assist errors.

The Board remands the claim for a skin condition, to include cystic acne and tinea versicolor, for further medical opinions regarding the etiology of these conditions.

The Board granted service connection for right and left knee disabilities, as well as a left eye disability. A 20 percent rating was granted for status post peptic ulcer with GERD, but the claim for a compensable rating for psoriasis was denied.

The Board denied service connection for various conditions, including an acquired psychiatric disorder, tinea cruris, vision loss, and bilateral hearing loss. The claim for initial ratings was also denied.

The Board remands the claims for service connection for bilateral hearing loss, residuals of back injury, residuals of excision of ingrown toenail, left ankle sprain, and pseudofolliculitis on face to obtain additional medical opinions.

The Board granted an initial 30 percent disability rating for dermatitis, resolving reasonable doubt in favor of the Veteran.

The Board denied service connection for bilateral pes planus, bilateral tinea pedis, and rhinitis as the evidence did not support a finding that these conditions were incurred in or caused by active military service.

The Board denied increased ratings for left knee strain and right leg shin splints, granted a 10 percent rating for right ankle strain, and remanded several other issues including service connection claims.

The Board granted service connection for eczema based on toxic exposure during the Veteran's deployment to Afghanistan, as supported by a positive nexus opinion. The claim for coronary artery disease (CAD) was remanded for further evidence.

The Board granted a separate rating of 10 percent for residual scar posterior neck associated with eczema/dermatitis, but denied an increased rating greater than 10 percent for the service-connected skin conditions.

The Board granted a 30 percent rating for pseudofolliculitis barbae, with eczematous dermatitis, tinea cruris, tinea pedis and vitiligo for the period on appeal prior to April 6, 2023, but denied a higher rating for the entire period on appeal.

The Board denied an earlier effective date, a higher initial rating for scars with underlying soft tissue damage, and a compensable rating for stasis dermatitis. The IBS claim was remanded.

The Board granted the restoration of a 50 percent rating for migraine headaches, effective May 23, 2024, due to an inadequate examination that supported the previous reduction.